Changes in Cerebral Cortical Aquaporin-1 Expression in Multiple Sclerosis by Pham, Thao
Portland State University
PDXScholar
University Honors Theses University Honors College
2015
Changes in Cerebral Cortical Aquaporin-1 Expression in Multiple
Sclerosis
Thao Pham
Portland State University
Let us know how access to this document benefits you.
Follow this and additional works at: http://pdxscholar.library.pdx.edu/honorstheses
This Thesis is brought to you for free and open access. It has been accepted for inclusion in University Honors Theses by an authorized administrator of
PDXScholar. For more information, please contact pdxscholar@pdx.edu.
Recommended Citation
Pham, Thao, "Changes in Cerebral Cortical Aquaporin-1 Expression in Multiple Sclerosis" (2015). University Honors Theses. Paper 153.
10.15760/honors.166
  
 
 
 
 
 
 
 
Changes in Cerebral Cortical Aquaporin-1 Expression in Multiple Sclerosis 
 
 
By Thao Pham 
Dr. Woltjer, Thesis Advisor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portland State University 
 
Honors Thesis 2015 
Abstract 
According to the National Multiple Sclerosis (MS) Society, MS, a demyelinating 
brain disease, affects approximately 2.3 million people worldwide. MS affects African-
Americans, Asians and Hispanics, but predominantly Caucasians of northern European 
ancestry. Women are three times more likely to be diagnosed with this disease, and 
individuals from populations with low vitamin D levels are more likely as well to develop 
the disease. Currently, there is no cure for MS, although some moderately effective 
treatments are available to slow some forms of disease progression. However, our 
understanding of the cause of MS, which would greatly facilitate treatment, remains very 
incomplete. One clue may be found in the presence of circulating antibodies to a brain 
protein, aquaporin-4, in the serum of patient with a form of MS, neuromyelitis optica, 
which affects chiefly the spinal cord and optic nerves. In this study, 
immunohistochemistry was used to determine abnormalities of this and a related protein, 
aquaporin 1, in brain tissues of deceased patients who were diagnosed with MS in 
comparison to control patients with normal brain tissues. Although MS affects mostly 
white matter, we found increased expression of aquaporin-1 in gray matter in the vicinity 
of demyelinated plaques in patients with MS compared to unaffected areas of brain in 
both MS and control patients. In contrast, expression of aquaporin-4 was relatively 
unchanged in these areas. We determined that increased aquaporin-1 expression was due 
to a change in the phenotype of astrocytes, a support cell of the brain, in the cerebral 
cortex in and near demyelinated areas in MS. This change in astrocytes may underlie 
some of the brain dysfunction observed in patients with MS. 
 
I. Introduction 
Neuromyelitis optica (NO) is a specific type of multiple sclerosis (MS) that 
targets the spinal cord and the optic nerve, resulting in impaired vision (Lennon, 2004). It 
is common to misdiagnose NO as multiple sclerosis; however, specific treatments for NO 
exist and show some efficacy (2004). In general, MS results from damaged or loss of 
myelin due to an immune attack on oligodendroglia, the myelin-producing cells of the 
brain (Okahara, 2014) that are found chiefly in the white matter, the major component of 
the deeper (noncortical) regions of brain tissue. This damage occurs in a patchy 
distribution, with demyelinated lesions commonly referred to as “plaques.” Hence, MS 
has been primarily considered a white matter disease. However, especially the deeper 
layers of the cerebral cortex contain lightly myelinated axons, and MS can affect these 
regions as well. Moreover, the inflammatory cells (macrophages and lymphocytes) that 
are found in demyelinated white matter plaques of MS may also extend into the cortex 
and be associated with loss of myelin there. 
Aquaporin channels found in a variety of sites in the body, and serve as 
specialized structures that transport water across a membrane. Aquaporin-4 is the major 
protein in the central nervous system that permits water flow, and is found mainly in 
processes of astrocytes.  Aquaporins regulate both normal water flow and in response to 
stress or injuries (Binder, 2013). As a result, a change in aquaporin-4 pathology is likely 
to result from various brain diseases. Aquaporin-1 plays an important role in water 
homeostasis in the brain after a traumatic brain injury; these can also function as a CO2 
transporter as well (Young, 2010). A role for aquaporin-1 and -4 in the development of 
MS and especially NO has been suggested by recent evidence that autoreactive antibodies 
to both of these proteins are found in the serum of patients with demyelinating diseases 
(Tzartos, 2013). Based on these observations, we undertook a study of changes in 
aquaporin-1 and -4 expression in the brain tissue of patients with MS.  We found the 
most striking changes to occur in aquaporin-1 in affected cortical regions in and near 
multiple sclerosis plaques. This discovery suggests that changes in aquaporin-expressing 
astrocytes in gray matter are a previously unrecognized feature of MS that may contribute 
to tissue dysfunction and symptoms in the disease. 
 
II. Literature Review 
Multiple sclerosis (MS) is an inflammatory disease that affects more than 2.1 
million people worldwide, most commonly appearing in individuals ranging from ages 
20-40 years old.  While some scientists try to pin this disease on toxins, viruses and even 
food, very little is known about the causes of multiple sclerosis.  However, patterns such 
as age, gender, and environmental factors can increase an individual’s chances of 
developing the disease. Treatment often includes antiviral drugs such as beta-interferon, 
which is effective in decreasing the number of attacks and slowing down progression of 
the disease.  Many patients, however, do not endure therapy since the drugs typically 
prescribed for MS have severe side effects (NMSS, n.d.). 
Currently, multiple sclerosis is classified as a white matter disease.  The bundles 
of axons that make up the white matter in the brain are normally covered in myelin. This 
white insulating fatty layer of myelin is destroyed in individuals with multiple sclerosis, 
causing axons to be left exposed and less capable of electrical signal conduction.  This 
characteristic of multiple sclerosis results in a loss of senses and problems with motor 
coordination (Wegner, 2009).  
While researchers initially looked more at the effects of multiple sclerosis on 
white matter and how parts of the brain work together, focus has recently shifted to the 
effects on the gray matter and how this disease affects thinking and learning over time.  
Little research has been done on the impact of gray matter in multiple sclerosis due to the 
ease of studying white matter, where lesions are most commonly found and are obvious 
as areas of white matter discoloration.  Scientists are able to observe degradation in 
myelin of multiple sclerosis patients by examining samples under a microscope and 
identifying pathologic features such as demyelination, the presence of inflammatory cells, 
and, in severe disease, axonal damage.  However, there is growing appreciation for 
involvement of gray matter as well, that over time may cause functional losses manifest 
as loss of cognitive function (Binder, 2013). 
I am interested in exploring this topic because since working in a neuropathology 
lab, I get the opportunity to observe different pathology of various brain diseases. By 
looking at the pathology of an individual’s brain, one can make a fairly good prediction 
about a patient’s symptoms and vice versa. By determining whether or not MS has an 
effect on the gray matter cortical region of the brain, new treatments can be discovered to 
improve cognitive outcomes in patients with long-standing disease. In addition, I am 
interested in promoting a broader consideration of the effects of MS on both white and 
gray matter in the brain and the implications of discoveries in this area on understanding 
the root causes and consequences of MS.  
 
III.  Methods 
Brain tissue from patients who had died with MS was obtained by the Oregon 
Brain Bank after consent was obtained from the next of kin to the deceased. Tissues were 
fixed for at least 10 days in neutral buffered formalin, dissected, and demyelinated 
plaques were grossly identified. Affected areas were embedded into paraffin cassette 
blocks. The blocks were then cut 7 micrometer thick, applied to a microscope slide, and 
left overnight to dry. Using a modification of the Abcam immunohistochemistry protocol. 
20 different, variably affected brain regions from different patients were stained using 
immunohistochemistry for aquaporin-1 and -4, as described in more detail below. 
On the first day, the slides were placed into a 600 Celsius oven for one hour to 
melt the paraffin, and then put into 6 washes of xylenes, and 2 washes of ethanol to 
remove the rest of the paraffin and permit tissue proteins to be exposed to solutions 
subsequently. The slides were then placed into 95% formic acid solution for five minutes 
to further enhance tissue protein exposure, then transferred to running water for another 
five minutes to wash off remaining formic acid. Afterwards, the slides were set into citric 
acid buffer that was already warmed and heated water bath for 45 minutes so that tissue 
antigens could be recovered. The slides were taken out to cool for then minutes, then 
dipped ten times in cold water before placing in phosphate buffer saline (PBS) for five 
minutes. They were then transferred into a 3% milk PBS solution for ten minutes to allow 
for blocking to prevent non-specific antibody binding. Antibodies dilutions were made in 
3% milk PBS solutions; anti-aquaporin-1 was diluted 1:500 and anti-aquaporin-4 was 
diluted to 1:1000 according to previous determinations of optimal binding and signal 
generation. The dilutions were applied on each designated slide and allowed to incubate 
in 00 C overnight for the antibodies to reach equilibrium binding to proteins in the tissues. 
The next day the slides were taken out, washed in PBS, and then placed back into 
3% milk in PBS blocking solution. Anti-rabbit secondary antibody solution was prepared 
in  3% milk in PBS. Secondary antibody solutions were made at a concentration of 1:200 
dilution of the manufacturer’s stock solution. The secondary antibody was applied on the 
slides and left to incubate in room temperature for one hour. After the incubation, the 
slides were first taken out and washed in water, and then in a methanol wash for 10 
minutes. The methanol wash was prepared using 8 parts anhydrous methanol, 1 part 
hydrogen peroxide, and 1 part distilled, deionized water to quench endogenous tissue 
peroxidases. The slides were then briefly put into water for rehydration and 2 washes of 
PBS each for two minutes. Meanwhile, a developing solution was made using the 
standard developer for diaminobenzidine (DAB) brown staining. 50-microliters drops of 
each A and B solutions in the Vector Laboraties Elite developer kit were used per 5 
milliliters of PBS. The developer was then applied on the slides and left to incubate at 
room temperature for one hour. Afterwards, the slides were taken out and washed with 
PBS. The brown stain was then made using DAB tablets dissolved in PBS; for every 
tablet used, 20mL of PBS was used to dissolve it, and 40 microliter of hydrogen peroxide 
was used to activate the enzymatic activity. The brown developer solution was then 
applied to the slides and left to incubate for 10 minutes while precipitate formed in areas 
of aquaporin content. The slides were then washed in water and then put into an 
automatic stainer to counter stain-using hemotoxylin & eosin. Coverslips were applied on 
the slides using glue and finally, each slide was evaluated under the microscope while 
observations were made and recorded with a Leica microscope camera. 
The same cases had a replicated set of slides cut and stained in hematoxalin and 
eosin (H&E). They were first baked in a 60-degree oven and then depariffinized and then 
went into an automatic stainer for counter-staining and then were stained with Luxol fast 
blue (LFB) myelin stain. These slides were then cover slipped and ultimately used to 
complement the observations that resulted from the immunohistochemistry stains and to 
compare these with the presence of demyelinating lesions. 
IV. Results 
 H&E/LFB-stained sections were examined to identify the presence of 
demyelinated plaques, inflammatory cells, and other morphologic features of MS brain 
tissue.  Subsequently, immunohistochemically stained sections were evaluated and the 
presence of aquaporin-1 and -4 were correlated with other tissue features. We found that 
normal white matter contained abundant aquaporin-1 and -4 and that these were only 
modestly decreased in areas of MS plaques (Figure 1). Normal cortex also contained 
abundant aquaporin-4 and this was not significantly decreased in gray matter affected by 
MS lesions (Figure 2). The most striking disease-associated changes were found in 
cerebral cortical expression of aquaporin-1, which was markedly increased in gray matter 
affected by MS, but essentially absent in normal cortex. Similarly, in control brains of 
individuals without multiple sclerosis, the cortical region of the brain showed little to no 
aquaporin-1 protein.  
Figure 1.  Representative hematoxalin- and eosin-stained sections of human brain tissue 
affected by multiple sclerosis, with luxol fast blue stain for myelin.  (A) Normal cerebral 
cortex from an area unaffected by MS, showing lightly myelinated axons stained blue 
(arrows) in a background of intact neurons and glial cells.  Larger dark blue structures are 
blood vessels that contain red blood cells that also are stained by this technique.  (B) 
Cerebral cortex in the area of a demyelinated plaque, with scant myelinated axons with a 
beaded degenerating morphology (arrow).  (C) Normal subcortical white matter, which is 
more richly and diffusely myelinated.  (D) White matter in a demyelinated MS plaque, 
showing an absence of axonal myelin; residual blood vessels are the only blue-staining 
structures. 
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Figure 2.  Aquaporin-1 expression in MS as determined by immunohistochemical 
staining of brain tissue sections with development of signal as brown color and 
hematoxalin (light blue) nuclear counterstain.  Representative areas are depicted.  (A) 
Normal cortex showing neurons and glial cells without significant aquaporin-1 
expression.  (B) Cortex in an area of demyelination, with astrocyte expression of 
abnormally high levels of aquaporin-1 in their processes.  (C)  Normal white matter, with 
abundant aquaporin-1 expression in glial cells.  (D)  Demyelinated white matter in an MS 
plaque, with modest depletion of aquaporin-1 along with other normal white matter 
components. 
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Figure 3.  Aquaporin-4 expression in MS as determined by immunohistochemical 
staining of brain tissue sections with development of signal as brown color and 
hematoxalin (light blue) nuclear counterstain.  Representative areas are depicted.  (A) 
Normal cortex showing aquaporin-4 expression by astrocytes in their processes.  (B) 
Cortex in an area of demyelination, with relatively normal distribution of astrocyte 
expression of abnormally high levels of aquaporin-4.  (C)  Normal white matter, with 
abundant aquaporin-4 expression in glial cells.  (D)  Demyelinated white matter in an MS 
plaque, with a subtly more course pattern of aquaporin-4 expression. 
 
V. Discussion 
Based on my research, the assumption that multiple sclerosis only affects the 
white matter in the brain conflicts with the findings that there are pathological changes in 
the aquaporin-1 protein distribution in the gray matter cortical region in areas near white 
matter plaques and especially in areas in which tissue damage including inflammatory 
lesions is adjacent or extends to involve the cerebral cortex. In comparison with control 
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brains, individuals affected with multiple sclerosis showed increased expression of 
aquaporin-1 proteins in these affected cortical region of their brains. This is the gray 
matter of the brain, and could be an explanation to why some individuals with MS 
demonstrates demented symptoms such as obsession, compulsion, interpersonal 
sensitivity, anger–hostility, phobic anxiety, paranoid ideation, psychoticism (Sarısoy, 
n.d.). Although there were changes of aquaporin-1 in the cortical region of the brain, this 
is not a specific marker for multiple sclerosis based on our observation of similar changes 
in this protein in other brain diseases (data not shown). However, its expression is a 
convenient way to identify and map affected cerebral cortical tissue in MS.  As noted 
previously, the presence of autoantibodies against aquaporin-1 or -4,   currently serve as a 
potential helpful marker for chronic demyelinated diseases such as NO (Tzartos, 2013).  
An interesting application of this finding could be to compare the IHC stains of 
aquaporin-1 & 4 with MRI images to determine the scanning parameters. Those scanning 
parameters, when precisely determined, could be used to optimize scans in living 
individuals for a more precise diagnosis of multiple sclerosis. More fundamentally, we 
have identified a novel change in astrocyte phenotype that correlates with cortical 
damage in MS.  Studies of the functional consequences of this change may inform us 
about additional and unanticipated ways in which MS affected the brain, and point to new 
disease therapies. 
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